• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情之前及期间心力衰竭和急性心肌炎相关死亡的全国趋势

National Trends in Heart Failure and Acute Myocarditis-Related Death Before and During the COVID-19 Pandemic.

作者信息

Siddiqi Rabbia, Farhan Syed H, Shah Syeda A, Mushahid Hasan, Nasir Muhammad M, Moukarbel George V

机构信息

University of Toledo OH USA.

Dow University of Health Sciences Karachi Pakistan.

出版信息

J Am Heart Assoc. 2025 May 20;14(10):e038987. doi: 10.1161/JAHA.124.038987. Epub 2025 May 15.

DOI:10.1161/JAHA.124.038987
PMID:40371584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12184568/
Abstract

BACKGROUND

The COVID-19 pandemic saw a rise in cardiovascular death, likely the result of disruptions in health care delivery and the infection itself. We examine mortality trends of heart failure (HF) and acute myocarditis (AM) before and during the pandemic and identify the most affected demographic subgroups.

METHODS AND RESULTS

We queried the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database for deaths from HF and AM before (1999-2019) and during (2020-2021) the COVID-19 pandemic. Age-adjusted mortality rates were calculated and stratified by sex, race and ethnicity, and age category. Trend-level analysis was performed using the Joinpoint Regression Program, which estimates average annual percentage change (AAPC) in age-adjusted mortality rate with corresponding 95% CI. A total of 7 366 944 HF deaths and 33 750 AM deaths occurred during 1999 to 2021. HF and AM mortality rates downtrended before the pandemic (AAPC, -0.63 and -2.42, respectively) but reversed during the pandemic (HF AAPC, 7.91; and AM AAPC, 20.3). Overall, during the pandemic, the age-adjusted mortality rate for both HF and AM was greater for men, non-Hispanic Black people, and adults aged ≥65 years. The sharpest increase was observed among non-Hispanic American Indian people (AAPC, 14.9), Hispanic people (AAPC, 9.63), and young adults (AAPC, 20.9) for HF and among women (AAPC 18.7), non-Hispanic Black people (AAPC, 15.6), and older adults (AAPC, 23.5) for AM.

CONCLUSIONS

The prepandemic downward trends of HF and AM mortality rates have reversed since 2020. Subgroups that had the greatest absolute mortality rates from both AM and HF in the pandemic years were men, non-Hispanic Black people, and older adults (aged ≥65 years).

摘要

背景

在新冠疫情期间,心血管疾病死亡率有所上升,这可能是医疗服务中断以及感染本身所致。我们研究了疫情之前和期间心力衰竭(HF)和急性心肌炎(AM)的死亡率趋势,并确定了受影响最大的人口亚组。

方法与结果

我们查询了美国疾病控制与预防中心的广泛在线流行病学研究数据库,以获取1999 - 2019年(疫情之前)和2020 - 2021年(疫情期间)因HF和AM导致的死亡数据。计算年龄调整死亡率,并按性别、种族和族裔以及年龄类别进行分层。使用Joinpoint回归程序进行趋势水平分析,该程序估计年龄调整死亡率的平均年度百分比变化(AAPC)及其相应的95%置信区间。1999年至2021年期间,共发生了7366944例HF死亡和33750例AM死亡。在疫情之前,HF和AM死亡率呈下降趋势(AAPC分别为 -0.63和 -2.42),但在疫情期间出现逆转(HF的AAPC为7.91;AM的AAPC为20.3)。总体而言,在疫情期间,HF和AM的年龄调整死亡率在男性、非西班牙裔黑人以及年龄≥65岁的成年人中更高。在HF方面,非西班牙裔美国印第安人(AAPC为14.9)、西班牙裔人(AAPC为9.63)和年轻人(AAPC为20.9)的死亡率增幅最大;在AM方面,女性(AAPC为18.7)、非西班牙裔黑人(AAPC为15.6)和老年人(AAPC为23.5)的死亡率增幅最大。

结论

自2020年以来,疫情前HF和AM死亡率的下降趋势已经逆转。在疫情期间,AM和HF绝对死亡率最高的亚组是男性、非西班牙裔黑人以及老年人(年龄≥65岁)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf7/12184568/70ec845dc016/JAH3-14-e038987-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf7/12184568/0ef09d5ce54d/JAH3-14-e038987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf7/12184568/70ec845dc016/JAH3-14-e038987-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf7/12184568/0ef09d5ce54d/JAH3-14-e038987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf7/12184568/70ec845dc016/JAH3-14-e038987-g003.jpg

相似文献

1
National Trends in Heart Failure and Acute Myocarditis-Related Death Before and During the COVID-19 Pandemic.新冠疫情之前及期间心力衰竭和急性心肌炎相关死亡的全国趋势
J Am Heart Assoc. 2025 May 20;14(10):e038987. doi: 10.1161/JAHA.124.038987. Epub 2025 May 15.
2
Projected Trends in Metabolic Dysfunction-Associated Steatotic Liver Disease Mortality Through 2040.到2040年代谢功能障碍相关脂肪性肝病死亡率的预测趋势
JAMA Netw Open. 2025 Jun 2;8(6):e2516367. doi: 10.1001/jamanetworkopen.2025.16367.
3
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
4
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
5
The impact of COVID-19 pandemic on mortality among adults receiving care for chronic health conditions in rural South Africa: findings from Agincourt health and socio-demographic surveillance system.2019冠状病毒病大流行对南非农村地区接受慢性病护理的成年人死亡率的影响:阿金库尔健康与社会人口监测系统的研究结果
Popul Health Metr. 2025 Jun 23;23(Suppl 2):30. doi: 10.1186/s12963-025-00388-8.
6
Breast Cancer Incidence Trends in Older US Women by Race, Ethnicity, Geography, and Stage.美国老年女性乳腺癌发病率按种族、族裔、地理位置和分期的趋势
JAMA Netw Open. 2025 Jun 2;8(6):e2516947. doi: 10.1001/jamanetworkopen.2025.16947.
7
Differences in Medicaid Enrollment and Spending Before and During the COVID-19 Pandemic.新冠疫情之前及期间医疗补助计划参保情况与支出的差异。
JAMA Netw Open. 2025 Jun 2;8(6):e2516569. doi: 10.1001/jamanetworkopen.2025.16569.
8
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
9
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Trends in cardiovascular risk factor prevalence, treatment, and control among US adolescents aged 12 to 19 years, 2001 to March 2020.2001 年至 2020 年 3 月期间,美国 12 至 19 岁青少年心血管风险因素流行率、治疗和控制的变化趋势。
BMC Med. 2024 Jun 13;22(1):245. doi: 10.1186/s12916-024-03453-5.
2
Demographic trends of cardiorenal and heart failure deaths in the United States, 2011-2020.2011-2020 年美国心肾和心力衰竭死亡的人口趋势。
PLoS One. 2024 May 29;19(5):e0302203. doi: 10.1371/journal.pone.0302203. eCollection 2024.
3
The COVID-19 Pandemic Was Associated with a Change in Therapeutic Management and Mortality in Heart Failure Patients.
新冠疫情与心力衰竭患者治疗管理及死亡率的变化有关。
J Clin Med. 2024 Apr 29;13(9):2625. doi: 10.3390/jcm13092625.
4
Determinants of Vaccine Hesitancy among African American and Black Individuals in the United States of America: A Systematic Literature Review.美国非裔和黑人个体疫苗犹豫的决定因素:一项系统文献综述
Vaccines (Basel). 2024 Mar 7;12(3):277. doi: 10.3390/vaccines12030277.
5
Cardiovascular Complications in Patients with Heart Failure and COVID-19: CARDIO COVID 19-20 Registry.心力衰竭合并新型冠状病毒肺炎患者的心血管并发症:CARDIO COVID 19-20注册研究
J Cardiovasc Dev Dis. 2024 Jan 23;11(2):34. doi: 10.3390/jcdd11020034.
6
Impact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroups.2019年冠状病毒病大流行对心血管疾病死亡率的影响及亚组内的对比分析。
Front Cardiovasc Med. 2024 Feb 7;11:1279890. doi: 10.3389/fcvm.2024.1279890. eCollection 2024.
7
Decoding acute myocarditis in patients with COVID-19: Early detection through machine learning and hematological indices.解读新型冠状病毒肺炎患者的急性心肌炎:通过机器学习和血液学指标进行早期检测
iScience. 2023 Nov 23;27(2):108524. doi: 10.1016/j.isci.2023.108524. eCollection 2024 Feb 16.
8
Determinants of COVID-19 vaccine-induced myocarditis.新冠病毒疫苗诱导的心肌炎的决定因素。
Ther Adv Drug Saf. 2024 Jan 27;15:20420986241226566. doi: 10.1177/20420986241226566. eCollection 2024.
9
Differential Mortality Among Heart Failure Patients Across Different COVID-19 Surges in New York City.不同 COVID-19 疫情期间纽约市心力衰竭患者的死亡率差异。
J Healthc Qual. 2024;46(4):197-202. doi: 10.1097/JHQ.0000000000000421. Epub 2024 Jan 12.
10
Rural, Regional, Racial Disparities in Telemedicine Use During the COVID-19 Pandemic Among US Adults: 2021 National Health Interview Survey (NHIS).美国成年人在新冠疫情期间远程医疗使用方面的城乡、地区和种族差异:2021年国家健康访谈调查(NHIS)
Patient Prefer Adherence. 2023 Dec 20;17:3477-3487. doi: 10.2147/PPA.S439437. eCollection 2023.